Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracycline-induced cardiotoxicity (review).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples